Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 88,110 Shares of Stock

Posted by George Bondi on Jul 1st, 2026

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) Director Matthew Shawn Morris sold 88,110 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $25.33, for a total transaction of $2,231,826.30. Following the completion of the sale, the director owned 76,651 shares of the company’s stock, valued at $1,941,569.83. This trade represents a 53.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total transaction of $1,601,159.96.
On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The stock was sold at an average price of $24.99, for a total transaction of $427,229.04.
On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The stock was sold at an average price of $24.96, for a total transaction of $25,384.32.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $25.73 on Wednesday. The business’s 50 day moving average price is $23.25 and its 200-day moving average price is $22.96. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company has a market cap of $3.24 billion, a price-to-earnings ratio of 160.82, a PEG ratio of 2.02 and a beta of 0.90.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. The company had revenue of $603.85 million during the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.Privia Health Group’s revenue was up 25.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.22 EPS. Sell-side analysts predict that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Analyst Ratings Changes

PRVA has been the subject of several research reports. Barclays lowered their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Weiss Ratings downgraded shares of Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Evercore set a $26.00 price target on Privia Health Group in a report on Wednesday, April 8th. Citigroup dropped their price objective on Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research note on Tuesday, March 3rd. Finally, Canaccord Genuity Group reduced their price objective on Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Privia Health Group has a consensus rating of “Moderate Buy” and a consensus price target of $31.15.

Check Out Our Latest Research Report on PRVA

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently modified their holdings of PRVA. Bayban purchased a new stake in Privia Health Group during the fourth quarter worth $26,000. Hantz Financial Services Inc. lifted its stake in shares of Privia Health Group by 456.2% during the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the last quarter. Global Retirement Partners LLC lifted its stake in shares of Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after purchasing an additional 1,351 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new stake in shares of Privia Health Group in the 4th quarter valued at about $93,000. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

(Get Free Report)

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.